Vijay Welle

DNP Doctor of Nursing Practice,  The Johns Hopkins Hospital 

Location: United States

Consulting Services

Case Consulting Grant Submission IT-Web-Mobile Technology

Areas Of Interest

Willis Ekbom Disease Cornua, Uterine SAM Domains Obstructive Asymmetric Septal Hypertrophy GTPase-Activating Proteins, ras E3 Protein, Adenovirus Mepivacaine Hydrochloride RPTK Ligand, Cek7 Riboflavin Mononucleotide Partial Seizures, Olfactory Cell Nucleus Divisions Cultural Body Modifications Follicle-Stimulating Hormone alpha M, Integrin Erythrocyte Aging Agonists, Calcium Channel L-Lactate Dehydrogenase (Cytochrome) Cells, Rouget HB-420 SK&F 883732 Cortical Dysplasias, Cerebral Test, Behavior Informatics, Health Bronchial Constrictions Podophyllotoxin, (5R-(5 alpha,5a alpha,8a beta,9 alpha))-Isomer Lipid Regulating Agents Chlamydia trachomatis Gromwell Cancer of Bladder Bone Misalignment Biobehavioral Model Oral Stage Psychotherapies, Rational Fucithalmic Paraneoplastic Neuropathies alpha-Dihydrotestosterone Receptor, 5

Professional Narrative

Dr. Vijay Welle was born in DuBois, Pennsylvania and is a graduate of Villanova University. He obtained his medical degree at Thomas Jefferson University in Philadelphia. His residency was at Thomas Jefferson and its affiliated Wills Eye Hospital, and he completed his training with fellowships at the University of Connecticut incataract andcorneal surgery.

Dr. Welle has thirty years’ experience in ophthalmic surgery,withspecialinterestin cataract surgery,corneal transplantation,andlaserrefractiveprocedures.Heisa founding member of Precision LASIK Group, Chief of Ophthalmology at The Hospital ofCentral Connecticut,andco-medical director of the Connecticut eye bank.

Employment

Assistant Professor, Harvard Med 2014
Medical Writer, Amgen 1991

Education

Doctor of medicine, Yale School of Medicine 2008
Master of Science in physician assistant, Perelman School of Medicine 1987

Referees

Publications

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Oberli MA, Reichmuth AM, Dorkin JR, Mitchell MJ, Fenton OS, Jaklenec A, Anderson DG, Langer R, Blankschtein D. Lipid Nanoparticle Assisted mRNA Delivery for Potent Cancer Immunotherapy. Nano Lett. 2017 Mar 8;17(3):1326-1335. doi: 10.1021/acs.nanolett.6b03329. Epub 2016 Dec 5. PMID: 28273716; PMCID: PMC5523404.

Platt RJ, Chen S, Zhou Y, Yim MJ, Swiech L, Kempton HR, Dahlman JE, Parnas O, Eisenhaure TM, Jovanovic M, Graham DB, Jhunjhunwala S, Heidenreich M, Xavier RJ, Langer R, Anderson DG, Hacohen N, Regev A, Feng G, Sharp PA, Zhang F. CRISPR- Cas9 knockin mice for genome editing and cancer modeling. Cell. 2014 Oct 9;159(2):440-55. doi: 10.1016/j.cell.2014.09.014. Epub 2014 Sep 25. PMID: 25263330; PMCID: PMC4265475.

Roberts TC, Langer R, Wood MJA. Advances in oligonucleotide drug delivery. Nat Rev Drug Discov. 2020 Oct;19(10):673-694. doi: 10.1038/s41573-020-0075-7. Epub 2020 Aug 11. PMID: 32782413; PMCID: PMC7419031.

Grants,Awards and Certifications

Grants :

No Grants Mentioned !!

Awards & Prizes :

Languages

Language Proficiency :

Translation Services :

Serving Millions of physicians and biomedical scientists in Industry and academia.

Site
Services
Follow Us
Contact Us
  • support@scienceandminds.com

Copyright © 2025 Trialect Inc. All rights reserved. | v2023.06.17.02